Work

Ofatumumab in combination with high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.7124

Authors: Januario E. Castro, Michael Y. Choi, Tomas Carvajal, Hongying Li, Danelle Frances James, Karen Messer, Thomas J. Kipps

Institution: Moores Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591412714

Cites:

Cited by: 1

Related to: 10